drugset / Trial / NCT04679376
Statins for the Treatment of NASH
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this research study is to determine whether the study drug, atorvastatin (Lipitor®), is safe and effective in improving the features of NASH.
Timeline
- Start
- 2023-01-25
- Primary completion
- 2026-12
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 40 mg | Oral |